0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R2,500 - R5,000 (2)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Structure-Activity Relationships for Development of Neurokinin-3 Receptor Antagonists - Reducing Environmental Impact... Structure-Activity Relationships for Development of Neurokinin-3 Receptor Antagonists - Reducing Environmental Impact (Hardcover, 1st ed. 2020)
Koki Yamamoto
R3,172 Discovery Miles 31 720 Ships in 12 - 17 working days

This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact. Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed. The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure-activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist. Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact.

Structure-Activity Relationships for Development of Neurokinin-3 Receptor Antagonists - Reducing Environmental Impact... Structure-Activity Relationships for Development of Neurokinin-3 Receptor Antagonists - Reducing Environmental Impact (Paperback, 1st ed. 2020)
Koki Yamamoto
R2,833 Discovery Miles 28 330 Out of stock

This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact. Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed. The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure-activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist. Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300
Casio LW-200-7AV Watch with 10-Year…
R999 R884 Discovery Miles 8 840
Eight Days In July - Inside The Zuma…
Qaanitah Hunter, Kaveel Singh, … Paperback  (1)
R340 R292 Discovery Miles 2 920
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300
Joseph Joseph Index Mini (Graphite)
R642 Discovery Miles 6 420
Mission Impossible 7 - Dead Reckoning
Tom Cruise, Hayley Atwell, … DVD  (1)
R179 Discovery Miles 1 790
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300
Hart Easy Pour Kettle (5L)
R389 R266 Discovery Miles 2 660
Little Black Book
Brittany Murphy, Ron Livingston, … DVD  (2)
R35 Discovery Miles 350
Dala Craft Pom Poms - Assorted Colours…
R34 Discovery Miles 340

 

Partners